Donor HLA−DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation

Donor HLA−DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation

Background. Individuals harbor preexisting HLA−DR/DQ−restricted responses to collagen type V (ColV) mediated by Th17 cells under Treg control, both specific to peptides that bind to inherited HLA class II antigens. Yet after transplant, the donor−DR type somehow influences graft outcome. We hypothes...

Full description

Bibliographic Details
Main Authors:	Ewa Jankowska−Gan, MS, Vrushali V. Agashe, PhD, Diego A. Lema, MD, Ying Zhou, MS, Laura Gonzalez Bosc, PhD, Jeremy A. Sullivan, PhD, Daniel S. Greenspan, PhD, William J. Burlingham, PhD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2020-10-01
Series:	Transplantation Direct
Online Access:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001062

Similar Items

Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
by: Melissa R Keller, et al.
Published: (2013-01-01)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
by: Nobuhisa Akamatsu, MD, PhD, et al.
Published: (2021-08-01)

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
by: Jennifer D. Motter, MHS, et al.
Published: (2023-08-01)

Extracellular Vesicle–associated GARP/TGFβ:LAP Mediates “Infectious” Allo-tolerance
by: William J. Burlingham, PhD, et al.
Published: (2023-06-01)

Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series
by: Annelies E. de Weerd, MD, PhD, et al.
Published: (2024-09-01)

Nonutilization of Kidneys From Donors After Circulatory Determinant of Death
by: Yingxin Lin, BSc, et al.
Published: (2022-06-01)

HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity
by: So-Young Park, MD, PhD, et al.
Published: (2024-05-01)

HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates
by: Joshua A. Rushakoff, MD, MPP, et al.
Published: (2022-05-01)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
by: Hajime Imamura, MD, et al.
Published: (2017-07-01)

Association of the Genetic Diversity of Killer Cell Immunoglobulin-like Receptor Genes and HLA-C Ligand in Saudi Women With Thyroid Cancer
by: Razan A. Altalhi MSc, et al.
Published: (2024-08-01)

Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation
by: Petra Hruba, PhD, et al.
Published: (2025-01-01)

Metabolic Characterization of Deceased Donor Kidneys Undergoing Hypothermic Machine Perfusion Before Transplantation Using 13C-enriched Glucose
by: Kamlesh Patel, PhD, et al.
Published: (2025-01-01)

Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting
by: James A. Hedley, MBiostats, et al.
Published: (2023-05-01)

Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support
by: Filip Depta, MD, PhD, et al.
Published: (2024-09-01)

Impact of Dialysis Time on Long-term Outcomes in HLA-identical Living Donor Kidney Transplant Recipients
by: Evelyn S. Ferreira, MSc, et al.
Published: (2024-09-01)

Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease
by: Javier García-Sancho, MD, PhD, et al.
Published: (2017-09-01)

Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
by: Renata von Glehn Ponsirenas, PhD, et al.
Published: (2018-09-01)

Absence of IL-6 Receptor Blockade Effect on the Outcomes of Transplant Glomerulopathy in the Absence of Anti-HLA Donor-specific Antibodies
by: Alberto Mella, MD, PhD, et al.
Published: (2024-06-01)

HLA Genotype Imputation Results in Largely Accurate Epitope Mismatch Risk Categorization Across Racial Groups
by: Gregory S. Cohen, BA, et al.
Published: (2024-07-01)

Is Mesenteric Panniculitis a Sign for Autoimmune Diabetes in Adults?
by: Evangelos C. Rizos, MD, PhD, et al.
Published: (2019-05-01)

A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease
by: Eun-Seok Shin, MD, PhD, et al.
Published: (2025-01-01)

Readmissions and costs in cadaveric and living-donor lobar lung transplantation: Analysis using a national database
by: Nobuyuki Yoshiyasu, MD, PhD, et al.
Published: (2023-12-01)

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
by: Yuichiro Okumura, MD, et al.
Published: (2017-09-01)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
by: Yohei Yamada, MD, PhD, et al.
Published: (2018-02-01)

The Effect of Genetic HLA Matching on Liver Transplantation Outcome: A Systematic Review and Meta-Analysis
by: Gautam Kok, MD, PhD, et al.
Published: (2023-09-01)

In silico analysis of missense variants of the C1qA gene related to infection and autoimmune diseases
by: Mohammed Y. Behairy, Ph.D, et al.
Published: (2022-12-01)

Rapid Metabolic Recovery of Donor Circulatory Death Liver Graft Using Whole Blood Perfusion: A Pig Study
by: Syuhei Yoshimoto, MS, et al.
Published: (2021-07-01)

Renal Autotransplantation and Extracorporeal Nephron-Sparing Surgery for De Novo Renal Cell Carcinoma in a Kidney Allograft
by: Shinichiro Ono, MD, PhD, et al.
Published: (2017-08-01)

Beneficial effects of extracorporeal membrane oxygenation over cardiopulmonary bypass in living-donor lobar lung transplantation
by: Masaki Ikeda, MD, et al.
Published: (2024-05-01)

Successful Living-donor Lobar Lung Transplantation With BK Virus-related Hemorrhagic Cystitis Throughout the Perioperative Period
by: Yasuaki Tomioka, MD, et al.
Published: (2024-01-01)

Outcomes of Living Kidney Donor Candidate Evaluations in the Living Donor Collective Pilot Registry
by: Bertram L. Kasiske, MD, et al.
Published: (2021-05-01)

TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case Report
by: Kei Kunimasa, MD, PhD, et al.
Published: (2022-05-01)

Men With a Terminal Illness Relax Their Criteria for Facial Attractiveness
by: Dariusz P. Danel PhD, et al.
Published: (2017-07-01)

Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure
by: Koji Saito, MD, et al.
Published: (2024-11-01)

Differential Willingness to Pay for Kidney Transplantation From Living and Deceased Donors: Empirical Study Among End-Stage Kidney Disease (ESKD) Patients
by: Limor Dina Gonen PhD, et al.
Published: (2022-12-01)

Three-dimensional Printing Technology for Deep Circumflex Iliac Artery Flap: From Recipient to Donor Sites
by: Wang-Yong Zhu, PhD, et al.
Published: (2021-06-01)

Effects of Adding Congested Segment IV to the Left Lateral Graft on Short-term Outcomes in Pediatric Living-donor Liver-transplant Recipients
by: Hikaru Aoki, MD, et al.
Published: (2023-11-01)

Long-term Outcomes After Kidney Transplantation From DBD Donors Aged 70 y and Older
by: Jørn Petter Lindahl, MD, PhD, et al.
Published: (2024-07-01)

The Possible Role of PD-1 Protein in –Mediated Immunomodulation and Cancer Treatment
by: Gan Wang PhD, et al.
Published: (2019-10-01)

In Response to Dr. Steven Sorscher
by: Shannon S. Zhang, MD, et al.
Published: (2023-01-01)